Indegene Limited (NSE:INDGN)
610.00
-3.35 (-0.55%)
Nov 6, 2026, 3:29 PM IST
Indegene Revenue
Indegene had revenue of 11.22B INR in the quarter ending September 30, 2026, with 39.55% growth. This brings the company's total for the last twelve months to 41.31B, up 35.84% year-over-year. In the fiscal year ending March 31, 2026, Indegene had annual revenue of 35.11B with 23.64% growth. That makes Indegene the 12,014th largest company in the world by revenue and 576th in India.
Revenue (ttm)
41.31B
Revenue Growth
+35.84%
P/S Ratio
3.56
Revenue / Employee
8.81M
Employees
4,687
Market Cap
146.95B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Indegene breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 35.11B | 6.71B | 23.64% |
| Mar 31, 2025 | 28.39B | 2.50B | 9.64% |
| Mar 31, 2024 | 25.90B | 2.84B | 12.29% |
| Mar 31, 2023 | 23.06B | 6.41B | 38.54% |
| Mar 31, 2022 | 16.65B | 6.84B | 69.76% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| NATCO Pharma | 34.85B |
| Marksans Pharma | 33.92B |
| Dr. Agarwal's Health Care | 23.58B |
| CORONA Remedies | 15.59B |
Indegene News
- 10 days ago - Indegene Transcript: Q2 26/27 - Transcripts
- 10 days ago - Indegene Quarterly report: Q2 2027 - Filings
- 10 days ago - Indegene Slides: Q2 2027 - Filings
- 3 months ago - Indegene Transcript: Q1 26/27 - Transcripts
- 3 months ago - Indegene Quarterly report: Q1 2027 - Filings
- 3 months ago - Indegene Slides: Q1 2027 - Filings
- 5 months ago - Indegene Slides: Investor presentation - Filings
- 6 months ago - Indegene Transcript: Q4 25/26 - Transcripts